Acquired Von Willebrand syndrome in patients with an axial flow left ventricular assist device

Circulation: Heart Failure

Volumn 3, Issue 6, 2010, Pages 675-681

  Meyer, Anna L ^a   Malehsa, Doris ^a   Bara, Christoph ^a   Budde, Ulrich ^b   Slaughter, Mark S ^c   Haverich, Axel ^a   Strueber, Martin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Aesculabor Hamburg GmbH   (Germany)

^c University of Louisville School of Medicine   (United States)

Author keywords

Heart assist device; Ventricle assist device; Von Willebrand disease type 2

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTICLE; BINDING AFFINITY; BLEEDING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CROSS-SECTIONAL STUDY; DEVICE REMOVAL; DISEASE SEVERITY; FEMALE; HEART ASSIST DEVICE; HEART LEFT VENTRICLE ASSIST DEVICE; HEMOSTASIS; HUMAN; LONG TERM CARE; MALE; OUTPATIENT; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; COHORT STUDIES; COLLAGEN; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HEMORRHAGE; HEMOSTASIS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLATELET AGGREGATION; REOPERATION; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VON WILLEBRAND DISEASE, TYPE 2; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 78650155308     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.109.877597     Document Type: Article

References (29)

1. Martin J, Siegenthaler MP, Friesewinkel O, Fader T, van de Loo A, Trummer G, Berchthold-Herz M, Beyersdorf F. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation - a preliminary study. Eur J Cardiothorac Surg. 2004; 25:971-977.
2. Lahpor J, Khaghani A, Hetzer R, Pavie A, Friedrich I, Sander K, Strueber M. European results with a continuous-flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg. 2010;37: 357-361.
3. Heyde EC. Gastrointestinal bleeding in aortic stenosis. N Engl J Med. 1958;259:196.
4. Warkentin TE, Moore JC, Morgan DG. Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet. 1992;340:35-37.
5. Pareti FI, Lattuada A, Bressi C, Zanobini M, Sala A, Steffan A, Ruggeri ZM. Proteolysis of von Willebrand factor and shear stress induced platelet aggregation in patients with aortic valve stenosis. Circulation. 2000;102: 1290-1295.
6. Tsai HM, Sussman Il, Nagel RL. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood. 1994;83:2171-2179.
7. Shida Y, Nishio K, Sugimoto M, Mizuno T, Hamada M, Koto S, Matsumoto M, Okushi K, Fujimura Y, Yoshioka A. Functional imaging of shear-dependent activity of ADAMTS 13 in regulating mural thrombus growth under whole blood flow conditions. Blood. 2008;111:1295-1298.
8. Sadler JE. Aortic stenosis, von Willebrand factor, and bleeding. N Engl J Med. 2003;394:323-325.
9. Sugimoto M, Matsui H, Mizuno T, Tsuji S, Miyata S, Matsumoto M, Matsuda M, Fujimura Y, Yoshioka A. Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions. Blood. 2003; 101:915-920.
10. Vincentelli A, Susen S, LeTourneau T, Six I, Fabre O, Juthier F, Bauters A, Decoene C, Goudernand J, Prat A, Jude B. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349:343-349.
11. Geisen U, Heilmann C, Beyersdorf F, Benk C, Berchtold-Herz M, Schlensak C, Budde U, Zieger B. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg. 2008;33:679-684.
12. Steinlechner B, Dworschak M, Birkenberg B, Duris M, Zeidler P, Fischer H, Milosevic L, Wieselthaler G, Wolner E, Quehenberger P, Jilma B. Platelet dysfunction in outpatients with left ventricular assist devices. Ann Thorac Surg. 2009;87:131-138.
13. Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol. 2009;53:2162-2167.
14. Goldstein D, Zucker M, Pagani FD, Frazier OH. Rotary ventricular assist devices. In: Frazier OH, Kirklin JK, eds. Mechanical Circulatory Support. ISHLT Monograph Series Vol 1. Oxford, England: Elsevier; 2006:77-104.
15. Kratzer MA, Born GV. Simulation of primary hemostasis in vitro. Hemostasis. 1985;15:357-362.
16. Fressinaud E, Veyradier A, Truchaud F, Martin I, Boyer-Neumann C, Trossaert M, Meyer D. Screeening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood. 1998;91: 1325-1331.
17. Mazurier C, Parquet-Gernez A, Goudemand M. Enzyme-linked immunoabsorbent assay of factor VIII-related antigen. Interest in study of von Willebrand's disease. Pathol Biol (Paris). 1977;25(suppl):18-24.
18. Brown JE, Bosak JO. An ELISA test for the binding of von Willebrand antigen to collagen. Thromb Res. 1986;43:303-311.
19. Budde U, Schneppenheim R, Plendl H, Dent J, Ruggeri ZM, Zimmerman TS. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost. 1990; 63:312-315.
20. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol. 2005;129:93-100.
21. Tiede A, Priesack J, Werwitzke S, Bohlmann K, Oortwijn B, Lenting P, Eisert R, Ganser A, Budde U. Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study. J Thromb Haemost. 2008;6:569-576.
22. Favaloro EJ, Koutts J. Laboratory assays for von Willebrand factor: relative contribution to the diagnosis of von Willebrand's disease. Pathology. 1997;29:385-391.
23. Cappell MS, Lebwohl O. Cessation of recurrent bleeding from gastrointestinal angiodysplasia after aortic valve replacement. Ann Intern Med. 1986;105:54-57.
24. Letsou GV, Shah N, Gregoric ID, Myers TJ, Delgado R, Frazier OH. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant. 2005;24:105-109. (Pubitemid 40094003)
25. Radovancevic R, Matijevic N, Bracey AW, Radovancevic B, Elayda M, Gregoric ID, Frazier OH. Increased leukocyte-platelet interactions during circulatory support with left ventricular assist devices. ASAIO J. 2009; 55:459-464.
26. Piot B, Signaud-Fiks M, Huet P, Fressinaud E, Trossaert M, Mercier J. Management of dental extractions in patients with bleeding disorders. Oral Surg Oral Med Oral Path Oral Radiol Endod. 2002;93:247-250.
27. Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients with von Willebrand disease type 1, 2 and 3. Clin Appl Thromb Hemost. 2007;13:14-34.
28. Strueber M, Sander K, Lahpor J, Ahn H, Litzler PY, Drakos SG, Musumeci F, Schlensak C, Friedrich I, Gustafsson R, Oertel F, Leprince P. HeartMate II left ventricular assist device; early European experience. Eur J Cardiothorac Surg. 2008;34:289-294.
29. Houël R, Mazoyer E, Boval B, Kirsch M, Vermès E, Drouet L, Loisance DY. Platelet activation and aggregation profile in prolonged external ventricular support. J Thorac Cardiovasc Surg. 2004;128:197-202.